Aggressive cancer cells halted

June 10, 2016, Leiden University

Zebrafish-human communication shows that cancer cells lacking a signaling protein are less able to develop aggressive metastatic properties. This discovery has been made by Claudia Tulotta. PhD defence 14 June.

Cancer cells create favourable circumstances for themselves in the human body. They do this by manipulating the body's direct environment, like immune cells, so that they do not attack but rather assist cancer cells. Scientists want to know how this interaction between cancer and immune calls works. This knowledge may provide possible starting points for halting the development of cancer.

Tulotta studied this interaction not in the , but in zebrafish embryos. Zebrafish has been increasingly used as a model to study cancer biology and similarities between zebrafish and human immune system are present. Tulotta injected fluorescent human cancer cells into the blood circulation of transparent two-day-old zebrafish embryos, with fluorescent blood vessels and . This made it possible for her to track the development and spread of the cancer cells in the living organism, while simultaneously interacting with surrounding zebrafish cells.

She studied two specific proteins. One – CXCR4 – is a product of cancer cells that is found on the surface of the cell. It plays an important role in the movement of cancer cells in response to another , CXCL12. This second protein can be found in both zebrafish and humans. It is produced by organs where tumor metastases are formed.

Tulotta: 'I have shown that cancer cells that produce a lot of CXCR4 behave more aggressively than cells with less CXCR4, in the . Aggressive cells leave the bloodstream and penetrate local tissues, where they can multiply. You can see this as an early step in the formation of metastases.

Tulotta applied two different methods to block the function of CXCR4. First, a pharmacological method: using a recently discovered inhibitor that prevents the protein from doing its work. The second method was genetic: CXCR4 gene function was impaired resulting in no protein production. Using both approaches, the aggressive behavior of cancer cells was halted.

Tulotta also carried out tests on zebrafish embryos that do not produce the CXCL12 protein. The introduced as part of the experiment did not demonstrate aggressive behaviour in these fish. 'This finding suggests that human and zebrafish cells communicate with each other, making the zebrafish embryo model suitable to study tumor behavior and interaction with the surrounding microenvironment.'

Tulotta believes there are opportunities for testing new CXCR4 inhibitors as a possible cancer treatment. The research may also be applied to drug development for other forms of cancer. Inhibiting CXCR4 was also shown to prevent metastasis initiation of Ewing sarcoma, a very rare form of bone cancer, in zebrafish.

Explore further: Signalling protein plays different roles in breast cancer and normal cells

Related Stories

Signalling protein plays different roles in breast cancer and normal cells

June 20, 2014
A key step in developing effective cancer therapies is identifying differences between normal, healthy cells and cancer cells – these differences can then be exploited to specifically kill tumour cells.

Researcher discovers a protein that spreads cancer

April 13, 2016
Nils Halberg at the University of Bergen has identified a protein that makes it possible for cancer cells to spread.

Fighting cancer with the help of someone else's immune cells

May 19, 2016
A new step in cancer immunotherapy: researchers from the Netherlands Cancer Institute and University of Oslo/Oslo University Hospital show that even if one's own immune cells cannot recognize and fight their tumors, someone ...

Zebrafish help decode link between calcium deficiency and colon cancer

December 13, 2013
A tiny, transparent fish embryo and a string of surprises led scientists to a deeper understanding of the perplexing link between low calcium and colon cancer.

What can we learn from zebrafish about human blood disorders?

May 6, 2016
Genetic regulation of the various types of blood cells in zebrafish and humans is highly similar, making it relatively easy and cost-effective to perform genetic, chemical, imaging and other molecular studies on this invaluable ...

Disrupting tumor cell 'microenvironment' suggests a new way to treat a prevalent childhood leukemia

June 8, 2015
Researchers at NYU Langone Medical Center and its Laura and Isaac Perlmutter Cancer Center are reporting a potentially important discovery in the battle against one of the most devastating forms of leukemia that accounts ...

Recommended for you

Pushing closer to a new cancer-fighting strategy

December 11, 2018
A molecular pathway that's frequently mutated in many different forms of cancer becomes active when cells push parts of their membranes outward into bulging protrusions, Johns Hopkins researchers report in a new study. The ...

Scientists have identified and modelled a distinct biology for paediatric AML

December 11, 2018
Scientists have identified and modelled a distinct biology for paediatric acute myeloid leukaemia, one of the major causes of death in children.

HER2 mutations can cause treatment resistance in metastatic ER-positive breast cancer

December 11, 2018
Metastatic breast cancers treated with hormone therapy can become treatment-resistant when they acquire mutations in the human epidermal growth factor receptor 2 (HER2) that were not present in the original tumor, reports ...

Taking uncertainty out of cancer prognosis

December 11, 2018
A cancer diagnosis tells you that you have cancer, but how that cancer will progress is a terrifying uncertainty for most patients. Researchers at Cold Spring Harbor Laboratory (CSHL) have now identified a specific class ...

Loss of two genes drives a deadly form of colorectal cancer, reveals a potential treatment

December 11, 2018
Colorectal cancers arise from earlier growths, called polyps, found on the inner surface of the colon. Scientists are now learning that polyps use two distinct molecular pathways as they progress to cancer, called the "conventional" ...

Successful anti-PD-1 therapy requires interaction between CD8+ T cells and dendritic cells

December 11, 2018
A team led by a Massachusetts General Hospital (MGH) investigator has found that successful cancer immunotherapy targeting the PD-1 molecule requires interaction between cytotoxic CD8+ T cells, which have been considered ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.